Drug pricing is hot. Want proof? According to The New York Times, there are six major drug pricing bills under consideration. For those who require it, here’s a refresher on the U.S. legislative process. Two of the proposed bills focus on the approval of generic medications. One would require pharma companies to give notice before price increases. Another would allow U.S. citizens to import cheaper drugs from other countries. Two others would require PBMs to disclose rebate levels and increase transparency. Additionally, President Trump is asking why the government does not negotiate prices it pays for Medicare. Net-net: there are lots of spaghetti strands being thrown at the drug pricing refrigerator, let’s see what sticks.